These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 23237719)

  • 1. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis.
    Olliaro PL; Coulibaly JT; Garba A; Halleux C; Keiser J; King CH; Mutapi F; N'Goran EK; Raso G; Scherrer AU; Sousa-Figueiredo JC; Stete K; Utzinger J; Vaillant MT
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008277. PubMed ID: 32569275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO; Rawago FO; Makworo NK; Muok EMO
    Parasit Vectors; 2024 Jun; 17(1):279. PubMed ID: 38943214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger.
    Garba A; Barkiré N; Djibo A; Lamine MS; Sofo B; Gouvras AN; Bosqué-Oliva E; Webster JP; Stothard JR; Utzinger J; Fenwick A
    Acta Trop; 2010 Sep; 115(3):212-9. PubMed ID: 20303925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
    Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
    Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda.
    Namwanje H; Kabatereine NB; Olsen A
    Parasitology; 2011 Oct; 138(12):1586-92. PubMed ID: 21349218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rice irrigation and schistosomiasis in savannah and forest areas of Côte d'Ivoire.
    Yapi YG; Briët OJ; Diabate S; Vounatsou P; Akodo E; Tanner M; Teuscher T
    Acta Trop; 2005 Feb; 93(2):201-11. PubMed ID: 15652334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children.
    Cleland CR; Tukahebwa EM; Fenwick A; Blair L
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):575-81. PubMed ID: 25059523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete Town, northeastern Ethiopia.
    Reta B; Erko B
    Trop Med Int Health; 2013 Nov; 18(11):1338-43. PubMed ID: 24103059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe.
    Midzi N; Sangweme D; Zinyowera S; Mapingure MP; Brouwer KC; Kumar N; Mutapi F; Woelk G; Mduluza T
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):759-66. PubMed ID: 18486169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety.
    Navaratnam AM; Sousa-Figueiredo JC; Stothard JR; Kabatereine NB; Fenwick A; Mutumba-Nakalembe MJ
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):400-7. PubMed ID: 22657533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.